Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CNSP market cap is 3.66M. The company's latest EPS is USD -0.5864 and P/E is -0.20.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.03M | -4.53M | -5.38M | -3.55M | -2.53M |
| Net Income | -4.02M | -4.52M | -5.38M | -3.55M | -2.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.83M | -9.46M | -14.03M | -15.27M | -18.87M |
| Net Income | -3.88M | -9.46M | -14.04M | -15.27M | -18.85M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.45M | 2.33M | 1.7M | 1.66M | 2.47M |
| Total Liabilities | 4M | 4.07M | 6.13M | 6.09M | 6.76M |
| Total Equity | 2.45M | -1.74M | -4.43M | -4.43M | -4.29M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.91M | 15.85M | 8.76M | 13.05M | 1.7M |
| Total Liabilities | 311k | 1.91M | 2.14M | 4.92M | 6.13M |
| Total Equity | 7.6M | 13.95M | 6.62M | 8.13M | -4.43M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.23M | -11.6M | -14.14M | -3.19M | -4.84M |
| Investing | N/A | -2k | -4k | N/A | N/A |
| Financing | 2.45M | 2.46M | 4.64M | 3.46M | 5.79M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.55M | -7.32M | -13.54M | -10.56M | -14.14M |
| Investing | -20k | -18k | -6k | -4k | -4k |
| Financing | 10.26M | 14.13M | 4.51M | 15.61M | 4.64M |
| Market Cap | 3.66M |
| Price to Earnings Ratio | -0.20 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.02 |
| Price to Book Ratio | -0.87 |
| Dividend Yield | - |
| Shares Outstanding | 32.15M |
| Average Volume (1 week) | 11.73M |
| Average Volume (1 Month) | 9.83M |
| 52 Week Change | -99.90% |
| 52 Week High | 118.995 |
| 52 Week Low | 0.0955 |
| Spread (Intraday) | 0 (3.23%) |
| Company Name | CNS Pharmaceuticals Inc |
| Address |
112 north curry street carson city, nevada 89703 |
| Website | https://www.cnspharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
